{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:14:49Z","timestamp":1790234089106,"version":"4.1.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"vor","delay-in-days":643,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tuberculosis is the leading cause of death among adults infected with human immunodeficiency virus (HIV), and rates of tuberculosis remain high even after preventive therapy. Among 908 HIV-infected adults in a trial of preventive treatment, we found self-reported alcohol consumption, low baseline CD4 count, high baseline viral load, and tuberculin skin test size &amp;gt;15 mm as independent risk factors for incident tuberculosis.<\/jats:p>","DOI":"10.1093\/ofid\/ofu120","type":"journal-article","created":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T04:08:27Z","timestamp":1419998907000},"source":"Crossref","is-referenced-by-count":20,"title":["Risk Factors for Developing Active Tuberculosis After the Treatment of Latent Tuberculosis in Adults Infected With Human Immunodeficiency Virus"],"prefix":"10.1093","volume":"2","author":[{"given":"Kojo","family":"Amoakwa","sequence":"first","affiliation":[{"name":"Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Martinson","sequence":"additional","affiliation":[{"name":"Perinatal HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa"},{"name":"Johns Hopkins University Center for Tuberculosis Research, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Moulton","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Barnes","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Center for Tuberculosis Research, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginah","family":"Msandiwa","sequence":"additional","affiliation":[{"name":"Perinatal HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Chaisson","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Johns Hopkins University Center for Tuberculosis Research, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,1,20]]},"reference":[{"key":"2020081006370306100_OFU120C1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"2020081006370306100_OFU120C2","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2020081006370306100_OFU120C3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"key":"2020081006370306100_OFU120C4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","article-title":"The prognosis of a positive tuberculin reaction in childhood and adolescence","volume":"99","author":"Comstock","year":"1974","journal-title":"Am J Epidemiol"},{"key":"2020081006370306100_OFU120C5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/INF.0b013e318236ae2b","article-title":"A strong tuberculin reaction in primary school children predicts tuberculosis in adolescence","volume":"31","author":"Leung","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"2020081006370306100_OFU120C6","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.5588\/ijtld.11.0015","article-title":"Dual skin tests with Mycobacterium avium sensitin and PPD to detect misdiagnosis of latent tuberculosis infection","volume":"15","author":"Larson","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020081006370306100_OFU120C7","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"2020081006370306100_OFU120C8","doi-asserted-by":"crossref","first-page":"828939","DOI":"10.1155\/2013\/828939","article-title":"Risk factors for tuberculosis","volume":"2013","author":"Narasimhan","year":"2013","journal-title":"Pulm Med"},{"key":"2020081006370306100_OFU120C9","first-page":"1501","article-title":"Body mass index and risk of tuberculosis and death","volume":"424","author":"Hanrahan","year":"2009","journal-title":"AIDS"},{"key":"2020081006370306100_OFU120C10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1590\/S0037-86822011005000034","article-title":"Co-infection and risk factors of tuberculosis in a Mexican HIV+ population","volume":"44","author":"Zenteno-Cuevas","year":"2011","journal-title":"Rev Soc Bras Med Trop"},{"key":"2020081006370306100_OFU120C11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-122-8-199504150-00003","article-title":"Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion","volume":"122","author":"Mellors","year":"1995","journal-title":"Ann Intern Med"},{"key":"2020081006370306100_OFU120C12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","article-title":"Prognosis in HIV-1 infection predicted by the quantity of virus in plasma","volume":"272","author":"Mellors","year":"1996","journal-title":"Science"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/1\/ofu120\/33620881\/ofu120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/1\/ofu120\/33620881\/ofu120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T10:45:03Z","timestamp":1597056303000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofu120\/1460196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofu120","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015]]},"published":{"date-parts":[[2015,1,1]]},"article-number":"ofu120"}}